Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency
- 1 January 1984
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 104 (1), 76-81
- https://doi.org/10.1016/s0022-3476(84)80593-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Danazol Increases Factor VIII and Factor IX in Classic Hemophilia and Christmas DiseaseNew England Journal of Medicine, 1983
- Increased susceptibility to severe pyogenic infections in patients with an inherited deficiency of the second component of complementThe Journal of Pediatrics, 1981
- Genetic Aspects of Deficiency of the Ninth Component of Complement in ManImmunobiology, 1980
- Replacement Therapy in Hereditary AngioedemaNew England Journal of Medicine, 1980
- Interaction between components of the human classical complement pathway and immobilized cibacron blue F3GAJournal of Immunological Methods, 1979
- Response of Variant Hereditary Angioedema Phenotypes to Danazol TherapyJCI Insight, 1979
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Serum complement profiles in infants and childrenThe Journal of Pediatrics, 1975
- Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.JCI Insight, 1975
- Increased Susceptibility to Infection Associated with Abnormalities of Complement-Mediated Functions and of the Third Component of Complement (C3)New England Journal of Medicine, 1970